64 results on '"Barbosa, Alexandre Naime"'
Search Results
52. The absence of the human platelet antigen polymorphism effect on fibrosis progression in human immunodeficiency virus-1/hepatitis C virus coinfected patients
- Author
-
Picelli, Natália, primary, Tanikawa, Aline Aki, additional, Grotto, Rejane Maria Tommasini, additional, Silva, Giovanni Faria, additional, Barbosa, Alexandre Naime, additional, Ferrasi, Adriana Camargo, additional, Silveira, Liciana Vaz de Arruda, additional, and Pardini, Maria Inês de Moura Campos, additional
- Published
- 2015
- Full Text
- View/download PDF
53. Avaliação das citocinas (ELISA e RT-PCR) e da fibrose hepática na coinfecção pelo HIV e vírus da hepatite C
- Author
-
Barbosa, Alexandre Naime [UNESP], Universidade Estadual Paulista (Unesp), and Meira, Domingues Alves [UNESP]
- Subjects
Hepatite C ,HIV (Virus) ,Medicina tropical ,Hepatitis c - Abstract
Made available in DSpace on 2014-06-11T19:31:28Z (GMT). No. of bitstreams: 0 Previous issue date: 2010-06-18Bitstream added on 2014-06-13T18:42:08Z : No. of bitstreams: 1 barbosa_an_dr_botfm.pdf: 1241955 bytes, checksum: 4ebec113ac46c15142666ca4f710746d (MD5) Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Universidade Estadual Paulista (UNESP) A aids e a hepatite C crônica são infecções caracterizadas por importante processo inflamatório contínuo, regulado por uma complexa interação entre citocinas. A persistência da atividade inflamatória crônica está intimamente relacionada com a progressão da patogênese da aids, bem como na indução de fibrose na hepatite C. Com o objetivo de avaliar o padrão de citocinas na infecção pelo HIV e na hepatite C crônica, as citocinas IL-2, IL-4, IL-10, TNF-α, INF-γ, TGF-β foram dosadas por Elisa e RT-PCR em cinco grupos: pacientes coinfectados pelo HIV/VHC (n=22), monoinfectados pelo HIV com supressão virológica pelo tratamento, e sem supressão virológica (n=17), monoinfectados pelo VHC (n=22) e um grupo controle composto por indivíduos doadores de sangue (n=10). IL-4 e IL-10 estiveram aumentadas consistentemente nos quatro grupos de estudo, determinando predomínio do perfil Th-2. INF-γ, TNF-α e TGF-β estiveram aumentados apenas nos grupos com infecção pelo VHC, com ou sem coinfecção pelo HIV. No grupo de monoinfectados pelo HIV com supressão virológica, a IL-2 dosada por RT-RCR esteve aumentada, porém os níveis séricos dosados por Elisa estavam normais. A alta produção de citocinas pró-inflamatórias INF-γ, TNF-α e TGF-β nos dois grupos de pacientes com infecção pelo VHC refletem o processo progressivo de acúmulo de inflamação e fibrose hepática. Já o predomínio de IL-4 e IL-10 em todos os grupos, citocinas ligadas ao perfil Th-2, demonstram a incapacidade de produção de uma resposta citotóxica Th-1, perpetuando a infecção e a inflamação crônica, mesmo naqueles indivíduos com supressão virológica pelo tratamento. Além de drogas antivirais, novos tratamentos imunomoduladores têm sido propostos para a erradicação viral, ou a interrupção das lesões causadas pelo estado inflamatório crônico... Both AIDS and chronic hepatitis C (HCV) are characterized by continuous inflammatory process, regulated by a complex interaction between cytokines. The persistence of chronic inflammatory activity is closely related to the progression of the pathogenesis of AIDS, as well as the induction of fibrosis in HCV. In order to analyze the role of cytokines in HIV/HCV coinfection and the fibrosis progression, IL-2, IL-4, IL-10, TNF- α, INF-γ, TGF-β were measured by ELISA and RT -PCR in five groups: HIV/HCV coinfected patients (n = 22), HCV monoinfected patients (n = 22), HIV monoinfected patients with and without virological suppression (n = 17) and a control group composed by blood donors (n = 10). Hepatic biopsy and METAVIR classification were performed in all HCV patients (n=44). The baseline characteristics (sex, age and race) of all groups were similar. No correlations were found between cytokines and hepatic fibrosis. IL-4 and IL-10 were consistently increased in the four study groups, findings associated to a Th-2 profile. INF- γ, TNF-α and TGF-β were increased only in groups with HCV infection. In the group of HIV monoinfected patients with virological suppression, IL-2 measured by RT-RCR was increased, but serum levels measured by ELISA were normal. The high production of proinflammatory cytokines INF-γ, TNF-α and TGF-β in two groups of patients with HCV infection reflect the gradual process of inflammation and liver fibrosis. The predominance of IL-4 and IL-10 in all study groups demonstrates an inability to promote a cytotoxic Th-1 response. Even in HIV monoinfected patients with virological suppression with increased IL-2 expression, Th-2 cytokines were the predominant, perpetuating the chronic inflammation. In addition to antiviral drugs, new immunomodulatory treatments have been proposed... (Complete abstract click electronic access below)
- Published
- 2010
54. Virologic and Immunologic Effectiveness at 48 Weeks of Darunavir–Ritonavir-Based Regimens in Treatment-Experienced Persons Living with HIV-1 Infection in Clinical Practice
- Author
-
Biscione, Fernando Martín, primary, Westin, Mateus Rodrigues, additional, Ribeiro, Karina Mota, additional, Estevam, Denize Lotufo, additional, Cardoso, Sandra Wagner, additional, Tenore, Simone Barros, additional, Neto, Lauro Ferreira da Silva Pinto, additional, Alencastro, Paulo Ricardo, additional, Suffert, Theodoro Armando, additional, de Moraes, Mônica Jacques, additional, Barbosa, Alexandre Naime, additional, Morejón, Karen Mirna Loro, additional, de Arruda, Érico Antônio Gomes, additional, Silveira, Jussara María, additional, Neto, José Luiz Andrade, additional, Greco, Dirceu Bartolomeu, additional, and Tupinambás, Unaí, additional
- Published
- 2013
- Full Text
- View/download PDF
55. Human gammaherpesviruses viraemia in HIV infected patients.
- Author
-
da Silva, Ana Paula Ferraz, Giron, Leila Bertoni, da Silva, Suzane Ramos, Barbosa, Alexandre Naime, de Barros Almeida, Ricardo Augusto Monteiro, and de Oliveira, Deilson Elgui
- Subjects
KAPOSI'S sarcoma ,HERPESVIRUS diseases ,LYMPHOPROLIFERATIVE disorders ,VIRAL load - Abstract
Background The Epstein-Barr virus (EBV) and Kaposi's sarcoma associated herpesvirus (KSHV) are consistently associated with lymphoproliferative diseases and cancers in humans, notably in patients with HIV. Aims Our aim was to evaluate whether EBV and/or KSHV viral loads regularly assessed in peripheral blood mononuclear cells (PBMC) correlate with clinical or laboratorial parameters retrieved for patients living with HIV. Methods This was a longitudinal study with a cohort of 157 HIV positive patients attending an academic HIV outpatient clinic in São Paulo State, Brazil. For each patient, up to four blood samples were collected over a 1 year clinical follow-up: on enrolment into the study, and after 4, 8 and 12 months. Total DNA was extracted from PBMC, and EBV and KSHV viral loads were assessed by real time quantitative PCR. Results Higher viral loads for EBV were significantly associated with high HIV viraemia, a greater number of circulating T CD8+ cells and lack of virological response to the antiretroviral treatment. KSHV viral load was undetectable in virtually all samples. Conclusions EBV viral load in PBMC correlated with the number of circulating T CD8+ lymphocytes and the response to the antiretroviral therapy in HIV infected patients. In contrast, KSHV was undetectable in PBMC, presumably an effect of the antiretroviral treatment. Therefore, either KSHV infection in the population studied was absent or viral load in PBMC was beyond the analytical limit of the assay. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
56. Virologic and immunologic effectiveness at 48 weeks of darunavir-ritonavir-based regimens in treatment-experienced persons living with HIV-1 infection in clinical practice: a multicenter Brazilian cohort.
- Author
-
Biscione, Fernando Martín, Westin, Mateus Rodrigues, Ribeiro, Karina Mota, Estevam, Denize Lotufo, Cardoso, Sandra Wagner, Tenore, Simone Barros, Neto, Lauro Ferreira da Silva Pinto, Alencastro, Paulo Ricardo, Suffert, Theodoro Armando, de Moraes, Mônica Jacques, Barbosa, Alexandre Naime, Morejón, Karen Mirna Loro, de Arruda, Erico Antônio Gomes, Silveira, Jussara María, Neto, José Luiz Andrade, Greco, Dirceu Bartolomeu, Tupinambás, Unaí, and de Arruda, Érico Antônio Gomes
- Abstract
Introduction: Published data addressing the effectiveness of darunavir-ritonavir (DRV/r)-based therapy for multiexperienced patients in developing countries are scarce. This study evaluated the 48-week virologic and immunologic effectiveness of salvage therapy based on DRV/r for the treatment of multidrug-experienced HIV-1-infected adults in Brazil.Materials and Methods: A multicenter retrospective cohort study was carried out with multidrug-experienced adults who were on a failing antiretroviral therapy and started a DRV/r-based salvage therapy between 2008 and 2010. The primary effectiveness end point was the proportion of patients with virologic success (plasma HIV-1 RNA <50 copies/mL at week 48).Results: At 48 weeks, 73% of the patients had HIV-RNA <50 copies/mL and a mean increase of 108 CD4 cells/mm(3). Higher baseline viral load, lower baseline CD4 count, younger age, and 3 or more DRV/r-associated resistance mutations were significantly predictive of virologic failure. Concomitant use of raltegravir was strongly associated with virologic success.Conclusion: The use of DRV/r-based regimens for salvage therapy is an effective strategy in the clinical care setting of a developing country. [ABSTRACT FROM AUTHOR]- Published
- 2014
- Full Text
- View/download PDF
57. ALTÍSSIMA TAXA DE RESPOSTA TERAPÊUTICA DA HEPATITE C EM UMA COORTE DE VIDA REAL NO BRASIL.
- Author
-
Albuquerqu Bertucci, Alexandre, Cardoso Macedo, Bruno, V. F. Proença, Stephanie, Sobral Antonelli, Thaysa, Sambugaro Pernomian, Laura, B. G. C. Rêgo, Amanda, Gomes Rodrigues, Beatriz, Faria Corrêa, Gabriel, Silva Cortês, Lucas, Norcia, Luiz Fernando, Andreotti, Paolo, and Barbosa, Alexandre Naime
- Published
- 2018
- Full Text
- View/download PDF
58. Zoonoses soroprevalence in people living HIV/AIDS
- Author
-
Brito, Flávio Gonçalves [UNESP], Universidade Estadual Paulista (Unesp), Langoni, Helio [UNESP], and Barbosa, Alexandre Naime [UNESP]
- Subjects
Aids ,Chagas ,Zoonoses ,HIV ,Leptospirosis ,Leptospirose ,Brucelose ,Toxoplasmose ,Brucellosis ,Toxoplasmosis - Abstract
Submitted by FLÁVIO GONÇALVES BRITO (britofilhoo@hotmail.com) on 2017-10-04T16:19:06Z No. of bitstreams: 1 TESE DE DOUTORADO final impresso flavio.pdf: 3777537 bytes, checksum: fb617dcd0c40ddcc6eeb32ed0bc1f810 (MD5) Rejected by Monique Sasaki (sayumi_sasaki@hotmail.com), reason: Solicitamos que realize uma nova submissão seguindo a orientação abaixo: O arquivo submetido está sem a ficha catalográfica. A versão submetida por você é considerada a versão final da dissertação/tese, portanto não poderá ocorrer qualquer alteração em seu conteúdo após a aprovação. Corrija esta informação e realize uma nova submissão contendo o arquivo correto. Agradecemos a compreensão. on 2017-10-04T17:40:59Z (GMT) Submitted by FLÁVIO GONÇALVES BRITO (britofilhoo@hotmail.com) on 2017-10-09T10:44:22Z No. of bitstreams: 2 TESE DE DOUTORADO final impresso 01 FICHA CATALOGRAFICA.pdf: 1508912 bytes, checksum: 2933176614c440b0061502a7637f9c64 (MD5) TESE DE DOUTORADO final impresso 01 FICHA CATALOGRAFICA.pdf: 1508912 bytes, checksum: 2933176614c440b0061502a7637f9c64 (MD5) Approved for entry into archive by Monique Sasaki (sayumi_sasaki@hotmail.com) on 2017-10-09T19:05:44Z (GMT) No. of bitstreams: 1 brito_fg_dr_bot.pdf: 1508912 bytes, checksum: 2933176614c440b0061502a7637f9c64 (MD5) Made available in DSpace on 2017-10-09T19:05:44Z (GMT). No. of bitstreams: 1 brito_fg_dr_bot.pdf: 1508912 bytes, checksum: 2933176614c440b0061502a7637f9c64 (MD5) Previous issue date: 2017-02-18 Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) O interesse pelo estudo das zoonoses, enfermidades comuns aos humanos e aos animais, aumentou acentuadamente nos últimos anos, sugerindo maior integração, conhecimento e relacionamento entre profissionais da área da saúde. Dentre estas zoonoses a brucelose, a toxoplasmose, a leptospirose e a doença de Chagas (DC) têm elevada importância veterinária e para a saúde pública, pela gravidade e potencial letalidade com que se apresentam em humanos. Atenção especial deve ser dada às pessoas vivendo com HIV/aids (PVHA), pois a imunossupressão à que estão sujeitas pode agravar ainda mais o seu quadro clínico, fato que gera necessidade de diagnósticos mais eficientes para essas infecções. Com o objetivo de determinar o perfil sorológico destas zoonoses em PVHA, atendidos no Serviço de Ambulatório Especializado de Infectologia “Domingos Alves Meira” (SAEI-DAM), entidade pertencente ao complexo de assistência da Faculdade de Medicina de Botucatu – UNESP, bem como relacionar aos hábitos, comportamentos e fatores de risco de exposição a essas doenças, além da obtenção de dados referentes ao grau de conhecimento em relação às zoonoses estudadas. Foram analisadas 236 amostras de soro desses pacientes para a presença de anticorpos anti- Brucella abortus, que mostraram-se negativas para todas as amostras. Para leptospirose quatro (1,69%) amostras foram positivas, para a toxoplasmose 154 (65%) amostras positivas, sendo 146 (94,8%) somente para anticorpos da classe IgG, dois (1,3%) somente para a classe IgM e seis (3,9%) para as duas classes de imunoglobulinas anti-Toxoplasma gondii. Para doença de Chagas encontrou-se quatro (1,69%) das amostras positivas para anticorpos anti Trypanosoma cruzi. Para neurotoxoplasmose e toxoplasmose ocular encontraram-se 21 (8,89%) e seis (2,54%) respectivamente de pacientes diagnosticados. The interest in the study of zoonoses, common diseases to humans and animals, has increased sharply in recent years, suggesting greater integration, knowledge and relationships among health professionals. Among these zoonoses, brucellosis, toxoplasmosis, leptospirosis and Chagas' disease (DC) are of high veterinary and public health importance due to the seriousness and potential lethality that they present in humans. Special attention should be given to people living with HIV / AIDS (PLWHA), since the immunosuppression to which they are subject may further aggravate their clinical condition, which generates a need for more efficient diagnoses for these infections. The objective of this study was to determine the serological profile of these zoonoses in PLWHA treated at the Domingos Alves Meira Specialized Ambulatory Service (SAEI-DAM), an entity belonging to the assistance center of Botucatu Medical School - UNESP, as well as to relate to the habits, behaviors and risk factors of exposure to these diseases, besides obtaining data regarding the degree of knowledge regarding the zoonoses studied, 236 serum samples of these patients were analyzed for the presence of anti-Brucella abortus antibodies, which showed Negative for all samples. For leptospirosis, four (1.69%) samples were positive for toxoplasmosis, with 154 (65%) positive samples, 146 (94.8%) only for IgG class antibodies, two (1.3%) for IgM class and six (3.9%) for the two classes of anti-Toxoplasma gondii immunoglobulins. For Chagas disease, four (1.69%) of the samples positive for anti-Trypanosoma cruzi antibodies were found. For neurotoxoplasmosis and ocular toxoplasmosis, 21 (8.89%) and 6 (2.54%) respectively of diagnosed patients were found.
- Published
- 2017
59. Effectiveness of wearing masks during the COVID-19 outbreak in cohort and case-control studies: a systematic review and meta-analysis.
- Author
-
Floriano I, Silvinato A, Bacha HA, Barbosa AN, Tanni S, and Bernardo WM
- Subjects
- Humans, Pandemics prevention & control, SARS-CoV-2, Case-Control Studies, Disease Outbreaks, COVID-19 prevention & control
- Abstract
Objective: To evaluate the efficacy of wearing a mask to prevent COVID-19 infection., Methods: This was a systematic review and meta-analysis of cohort and case-control studies, considering the best level of evidence available. Electronic databases (MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and Clinical Trials.gov) were searched to identify studies that evaluated the effectiveness of wearing masks compared with that of not wearing them during the COVID-19 pandemic. Risk of bias and quality of evidence were assessed using the Cochrane risk of bias tool and the Grading of Recommendations Assessment, Development, and Evaluation., Results: Of the 1,028 studies identified, 9 met the inclusion criteria (2 cohort studies and 7 case-control studies) and were included in the analysis. The meta-analysis using cohort studies alone showed statistically significant differences, wearing a cloth mask decreased by 21% [RD = -0.21 (95% CI, -0.34 to -0.07); I2 = 0%; p = 0,002] the risk of COVID-19 infection, but the quality of evidence was low. Regarding case-control studies, wearing a surgical mask reduced the chance of COVID-19 infection [OR = 0.51 (95% CI, 0.37-0.70); I2 = 47%; p = 0.0001], as did wearing an N95 respirator mask [OR = 0.31 (95% CI, 0.20-0.49); I2 = 0%; p = 0.00001], both with low quality of evidence., Conclusions: In this systematic review with meta-analysis, we showed the effectiveness of wearing masks in the prevention of SARS-CoV-2 infection regardless of the type of mask (disposable surgical mask, common masks, including cloth masks, or N95 respirators), although the studies evaluated presented with low quality of evidence and important biases.
- Published
- 2024
- Full Text
- View/download PDF
60. Brazilian pulmonology guidelines on Delphi panel for post-coronavirus disease 2019.
- Author
-
Tanni SE, Baldi BG, Godoy I, Bacha HA, Barbosa AN, and Bernardo WM
- Subjects
- Humans, Brazil, Delphi Technique, COVID-19, Pulmonary Medicine
- Published
- 2023
- Full Text
- View/download PDF
61. Use of anticoagulants in patients with COVID-19: an update of a living systematic review and meta-analysis.
- Author
-
Batista DR, Floriano I, Silvinato A, Bacha HA, Barbosa AN, Tanni SE, and Bernardo WM
- Subjects
- Humans, Anticoagulants therapeutic use, SARS-CoV-2, COVID-19
- Published
- 2023
- Full Text
- View/download PDF
62. Human monkeypox disease (MPX).
- Author
-
Farahat RA, Sah R, El-Sakka AA, Benmelouka AY, Kundu M, Labieb F, Shaheen RS, Abdelaal A, Abdelazeem B, Bonilla-Aldana DK, Franco-Paredes C, Henao-Martinez AF, Garout MA, León-Figueroa DA, Pachar M, Suárez JA, Ramirez JD, Paniz-Mondolfi A, Rabaan AA, Al-Tawfiq JA, Nishiura H, Ortiz-Martínez Y, Garcia-Robledo JE, Cimerman S, Barbosa AN, Pagliano P, Zambrano-Sanchez G, Cardona-Ospina JA, Bížová B, and Rodriguez-Morales AJ
- Abstract
Monkeypox is a rare viral infection, endemic in many central and western African countries. The last international outbreak of monkeypox reported outside Africa occurred back in 2003. However, monkeypox has reemerged at a global scale with numerous confirmed cases across the globe in 2022. The rapid spread of cases through different countries has raised serious concerns among public health officials worldwide prompting accelerated investigations aimed to identify the origins and cause of the rapid expansion of cases. The current situation is reminiscent of the very early stages of the still ongoing COVID-19 pandemic. Overlapping features between these, two seemingly alike viral entities include the possibility for airborne transmission and the currently unexplained and rapid spread across borders. Early recognition of cases and timely intervention of potential transmission chains are necessary to contain further outbreaks. Measures should include rapid and accurate diagnosis of cases meeting case definitions, active surveillance efforts, and appropriate containment of confirmed cases. Governments and health policymakers must apply lessons learned from previous outbreaks and start taking active steps toward limiting the recent global spread of monkeypox. Herein, we discuss the status of the current monkeypox outbreaks worldwide, the epidemiological and public health situation at a global scale and what can be done to keep at bay its further expansion and future global implications., Competing Interests: Declaration of competing interest The authors have no conflict of interest., (Copyright © 2016 - 2022 InfezMed.)
- Published
- 2022
- Full Text
- View/download PDF
63. Latin America: Situation and preparedness facing the multi-country human monkeypox outbreak.
- Author
-
Rodriguez-Morales AJ, Lopardo G, Verbanaz S, Orduna T, Lloveras S, Azeñas-Burgoa JM, Escalera-Antezana JP, Alvarado-Arnez LE, Barbosa AN, Diaz-Quijano F, Cimerman S, Chaves TDSS, Rodriguez-Morales AG, Perret C, Méndez CA, Riera JA, Bonilla-Aldana DK, Camacho-Moreno G, Mendoza H, Rodriguez-Sabogal IA, Oñate J, Escobedo AA, Thormann M, Roque Y, Zambrano PG, Carrero Y, Sandoval N, Zambrano L, Franco-Paredes C, Chacon-Cruz E, Lopez-Delgado I, Cuadra-Sánchez C, Pachar-Flores M, Correa R, Rodriguez-Enciso HD, Rotela-Fisch V, Maquera-Afaray J, Herrera-Añazco P, Benites-Zapata V, Savio-Larriera E, Ramírez JD, Paniz-Mondolfi A, Risquez A, Forero-Peña DA, Torres JR, and Suarez JA
- Abstract
Competing Interests: All authors declare no competing of interest. GC-M has received an independent grant from Pfizer through the Asociación Colombiana de Infectologia ACIN- capitulo central; speaker fees from Pfizer, Sanofi Pasteur and Biomerieux; and participated in Advisory Boards for MSD and Sanofi Pasteur.
- Published
- 2022
- Full Text
- View/download PDF
64. Use of remdesivir in patients with COVID-19: a systematic review and meta-analysis.
- Author
-
Tanni SE, Silvinato A, Floriano I, Bacha HA, Barbosa AN, and Bernardo WM
- Subjects
- Adenosine Monophosphate analogs & derivatives, Alanine analogs & derivatives, Antiviral Agents therapeutic use, Humans, Observational Studies as Topic, SARS-CoV-2, Treatment Outcome, COVID-19 Drug Treatment
- Abstract
Objective: Studies in the literature regarding the use of remdesivir to treat COVID-19 patients have shown conflicting results. This study sought to answer questions related to the use of remdesivir for the treatment of patients hospitalized with moderate to severe COVID-19., Methods: This was a systematic review and meta-analysis including phase 3 randomized clinical trials (RCTs) and observational cohort studies selected from various databases, comparing patients hospitalized with moderate to severe COVID-19 receiving remdesivir and controls., Results: A total of 207 studies were retrieved, 9 of which met the eligibility criteria and were included in the study. The meta-analysis using RCTs alone showed no statistically significant differences regarding mortality or use of mechanical ventilation/extracorporeal membrane oxygenation between remdesivir and control groups, and the quality of evidence was moderate and low, respectively. The use of remdesivir increased the recovery rate by 6% (95% CI, 3-9); p = 0.004) and the clinical improvement rate by 7% (95% CI, 1-14); p = 0.02). Additionally, no significant differences in mortality were found between remdesivir and control groups when the meta-analysis used observational cohort studies alone (risk difference = -0.01 (95% CI, -0.02 to 0.01; p = 0.32), the quality of evidence being moderate, and the risk of adverse events was 4% ([95% CI, -0.08 to 0.01]; p = 0.09)., Conclusions: The use of remdesivir for the treatment of patients with moderate to severe COVID-19 had no significant impact on clinically important outcomes.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.